Clinical validation of prospective liquid biopsy monitoring in patients with wild-type RAS metastatic colorectal cancer treated with FOLFIRI-cetuximab

por Toledo, Rodrigo A., Cubillo, Antonio, Vega, Estela, Garralda, Elena, Alvarez, Rafael, de la Varga, Lisardo U., Pascual, Jesús R., Sánchez, Gema, Sarno, Francesca, Prieto, Susana H., Perea, Sofía, Lopéz-Casas, Pedro P., López-Ríos, Fernando, Hidalgo, Manuel
Publicado 2016

Primary Chemoradiotherapy Treatment (PCRT) for HER2+ and Triple Negative Breast Cancer Patients: A Feasible Combination

por Ciérvide, Raquel, Montero, Ángel, García-Rico, Eduardo, García-Aranda, Mariola, Herrero, Mercedes, Skaarup, Jessica, Benassi, Leticia, Barrera, Maria José, Vega, Estela, Rojas, Beatriz, Bratos, Raquel, Luna, Ana, Parras, Manuela, López, María, Delgado, Ana, Quevedo, Paloma, Castilla, Silvia, Feyjoo, Margarita, Higueras, Ana, Prieto, Mario, Suarez-Gauthier, Ana, Garcia-Cañamaque, Lina, Escolán, Nieves, Álvarez, Beatriz, Chen, Xin, Alonso, Rosa, López, Mercedes, Hernando, Ovidio, Valero, Jeannette, Sánchez, Emilio, Ciruelos, Eva, Rubio, Carmen
Publicado 2022

Palbociclib combined with endocrine therapy in heavily pretreated HR(+)/HER2(-) advanced breast cancer patients: Results from the compassionate use program in Spain (PALBOCOMP)

por Manso, Luis, Hernando, Cristina, Galán, María, Oliveira, Mafalda, Cabrera, Miguel A., Bratos, Raquel, Rodríguez, César A., Ruiz-Borrego, Manuel, Blanch, Salvador, Llombart-Cussac, Antonio, Delgado-Mingorance, Juan I., Álvarez-Busto, Iñaki, Gallegos, Isabel, González-Cortijo, Lucía, Morales, Serafín, Aguirre, Elena, Hernando, Blanca A., Ballesteros, Ana, Alés-Martínez, José E., Reboredo, Cristina, Oltra, Amparo, González-Cao, María, Santisteban, Marta, Malón, Diego, Echeverría, Isabel, García-Garre, Elisa, Vega, Estela, Servitja, Sònia, Andrés, Raquel, Robles, Carlos E., López, Rafael, Galve, Elena, Echarri, María J., Legeren, Marta, Moreno, Fernando
Publicado 2020